SignalMacro

Lycia Therapeutics Launches U.S. IPO For Food Allergy, Graves' Disease Pipeline

Lycia Therapeutics launches U.S. IPO targeting food allergy and Graves' disease pipeline.

What changed

Lycia Therapeutics launches U.S. IPO targeting food allergy and Graves' disease pipeline.

Why it matters

Lycia Therapeutics launches U.S. IPO targeting food allergy and Graves' disease pipeline. — impact context not separately stored; see What changed.

Sources